PI3Kα-specific inhibitor BYL-719 synergizes with cisplatin in vitro in PIK3CA-mutated ovarian cancer cells
Benoît Thibault(Centre National de la Recherche Scientifique), Julie Guillermet‐Guibert(Université Toulouse III - Paul Sabatier)
Cited by 2
Related Papers
Pancreatic cell plasticity and cancer initiation induced by oncogenic Kras is completely dependent on wild-type PI 3-kinase p110α
|Genes & Development|2014|127
Novel Role for p110β PI 3-Kinase in Male Fertility through Regulation of Androgen Receptor Activity in Sertoli Cells
|PLoS Genetics|2015|51
Meat enriched-diet and inflammation promote PI3Kα-dependent pancreatic cell plasticity that limit tissue regeneration
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0